Skip to main content

Table 1 Study treatments

From: Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis

Anti-TNF drug Posology according to SPC Route Full-dose group Reduced-dose group
Adalimumab 40 mg every 2 weeks SC 40 mg every 2 weeks 40 mg every 3 weeks
Etanercept 25–50 mg every 3–7 days SC 25 mg every 3 days or
50 mg every 7 days
50 mg every 10 days
Golimumab 50 mg every month SC 50 mg every 4 weeks 50 mg every 6 weeks
Infliximab 5 mg/Kg every 6–8 weeks IV 5 mg/Kg every 6–8 weeks 3 mg/Kg every 8 weeks
  1. SPC Summary of Product Characteristics, SC subcutaneous, IV intravenous